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A B S T R A C T   
Within preclinical research, the pig has become an important model in regulatory toxicology and pharmacokinetics, to assess oral dosage forms and to compare 
different formulation strategies. In addition, there are emerging application of the pig model to asses clinical dosing conditions in the fasted and fed state. In this 
study, the gastrointestinal transit conditions in male landrace pigs were studied with a telemetric motility capsule under fasted and postprandial conditions. The 
whole gut transit time (WGTT) was determined by administering a SmartPill® capsule to four landrace pigs, under both fasted and fed state conditions in a cross-over 
study design. Overall, this study found that small intestinal transit in landrace pigs ranged from 2.3 – 4.0 h, and was broadly similar to reported human estimates and 
was not affected by the intake conditions. Gastric emptying was highly variable and prolonged in landrace pigs ranging from 20 – 233 h and up to 264 h in one 
specific case. Under dynamic conditions pigs have a low gastric pH comparable to humans, however a high variability under fasted conditions could be observed. The 
comparison of the data from this study with a recent similar study in beagle dogs revealed major differences between gastric maximum pressures observed in landrace 
pigs and dogs. In the porcine stomach maximum pressures of up to 402 mbar were observed, which are comparable to reported human data. Intestinal maximum 
pressures in landrace pigs were in the same range as in humans. Overall, the study provides new insights of gastrointestinal conditions in landrace pigs, which can 
lead to more accurate interpretation of in vivo results obtained of pharmacokinetic studies in preclinical models. While small intestinal transit conditions, GI pH and 
pressures were similar to humans, the prolonged gastric emptying observed in pigs need to be considered in assessing the suitability of the pig model for assessing in 
vivo performance of large non-disintegrated oral drug products.   
1. Introduction 
Over the last decade, pigs have been increasingly proposed as a 
preclinical model in regulatory toxicology and pharmacokinetics (Bode 
et al., 2010; Sjogren et al., 2014). A principle advantage of the pig model 
is the similarity between the anatomy and physiology of the gastroin-
testinal (GI) tract in humans and pigs. For example, the gastric pH in pigs 
and human is similar ranging from 1.15 – 4.0 in pigs and 1.0 – 3.5 in 
humans (Henze et al., 2018b). Pigs, like humans, are omnivorous and 
they have similar digestive system. Moreover, the intestinal microbiome 
of the colon and the digestion characteristics of the small intestines are 
considered to be similar to human (Henze et al., 2018b; Suenderhauf 
and Parrott, 2013; Swindle and Smith, 1998). The pig model has pre-
viously been used to investigate various formulation strategies that 
enhance oral bioavailability of poorly water soluble drugs (Griffin et al., 
2014; Henze et al., 2018b; McCarthy et al., 2017; O’Shea et al., 2015; 
Thomas et al., 2014). Furthermore, pigs have been shown to be suitable 
to explore food dependent bioavailability (Henze et al., 2019, 2020b), as 
well as novel gastro-retentive dosage forms (Brayden and Baird). The 
two most common breeds used in pharmaceutical research are landrace 
pigs and Göttingen minipigs and are therefore the most widely charac-
terised physiologically (Bode et al., 2010; Henze et al., 2018b). In gen-
eral, both breeds display similar GI physiology, albeit breed specific 
differences have been reported (Helke and Swindle, 2013). . Whereas 
historically dogs have been more commonly employed as a large animal 
model in preclinical drug development, and hence canine GI physiology 
has been extensively characterised in the literature (Hatton et al., 2015; 
Koziolek et al., 2019; Sjogren et al., 2014). In contrast, GI physiology of 
the pig is less well characterised. While it is clear that each preclinical 
species have their relative similarities and differences to human GI 
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conditions, it is also imperative that a complete comparison of repre-
sentative GI physiology is available for each preclinical species, using 
comparable techniques to those performed in humans. Therefore, while 
there is no ‘ideal’ preclinical model in terms of representing all aspects of 
human GI conditions, selection of the most appropriate species for 
evaluating a given drug product and/or dosage form should be informed 
by how closely it simulates human conditions. 
Relative to humans, gastric transit times have been reported to be 
prolonged in pigs, although estimates of porcine gastric emptying have 
been reported to show high inter-individual and inter-study variability 
(Davis et al., 2001; Henze et al., 2018a; Hossain et al., 1990; Suender-
hauf et al., 2014). As gastric transit time is a fundamental factor influ-
encing drug absorption, it is crucial to get accurate insights into transit 
times, as well as pH and pressure profiles in pigs. To investigate these 
conditions, several techniques are available such as sampling of intes-
tinal fluids, imaging techniques (scintigraphy) or telemetric capsules 
(Hens et al., 2017). One of the first published studies to explore gastric 
conditions in pigs involved the use of a telemetric capsule to investigate 
gastric emptying in Yucatan minipigs (Oberle and Das, 1994). This study 
provided first insights into GI conditions in pigs and reported similar pH 
ranges between pigs and humans, one pig displayed a prolonged gastric 
transit time (> 54 h). While the study was useful in terms of demon-
strating a prolonged gastric transit in pigs, other key factors like the 
impact of a high-fat, high-caloric meal on GI transit were still lacking. An 
alternative technique to evaluate gastric emptying is the labelling of 
dosage forms with a suitable gamma-emitting radio nuclide, the GI 
transit of the dosage form can therefore be tracked using gamma scin-
tigraphy. Davis et al. reported that gastric emptying time after a light 
meal ranged between 1.5 - 6 h in landrace pigs, based upon in-
vestigations of the gastric emptying of liquids and solid dosage forms in 
pigs using gamma scintigraphy (Davis et al., 2001). In a subsequent 
study by the same group, it was reported that the mean time to empty 50 
% of a dosed liquid to be 1.4 h in pigs. The gastric emptying rate of 
pellets in pigs (pellet size of 0.85 -1.4 mm), was reported to be 2.2 h for 
50 % of the pellets to enter the small intestine and 4 h after dosing a 
non-disintegrating tablet (Davis et al., 2001). Another approach, was the 
use of paracetamol to evaluate gastric emptying. Paracetamol is known 
to be poorly absorbed in the stomach, but rapidly absorbed upon entry 
into the small intestine, which makes it suitable marker when examining 
gastric emptying rate (Suenderhauf et al., 2014). In recent studies, the 
paracetamol absorption technique has been used to investigate gastric 
emptying in landrace pigs and Göttingen minipigs (Christiansen et al., 
2015; Henze et al., 2018a; Henze et al., 2019). The pharmacokinetic 
results of paracetamol demonstrated no significant differences between 
fasted and fed state groups. Due to the lack of a difference between 
fasted and fed study groups, it was hypothesized that paracetamol may 
not represent a suitable marker of food induced changes in gastric 
emptying (Henze et al., 2019). 
Apart from supporting formulation development, the pig model can 
also be used to predict food effect on oral drug bioavailability. We have 
recently reported that the food effect of fenofibrate and venetoclax can 
be reliably predicted with the aid of landrace pigs. Thereby, a key aspect 
was the establishment of a standardized food effect study protocol, 
utilizing the FDA style high-fat high-caloric meal to mimic postprandial 
conditions present in human food effect studies (Henze et al., 2019, 
2020b). Understanding GI physiology under preclinical study conditions 
is crucial for the interpretation of the results obtained in vivo. The 
SmartPill® has recently been used to investigate canine and human GI 
conditions under fasted and fed state (high caloric meal). It is a 
non-invasive method to evaluate pH, temperature and pressure along 
the GI tract (Koziolek et al., 2019; Koziolek et al., 2015; Schneider et al., 
2016). The SmartPill® is an ingestible capsule (26 × 13 mm), and 
facilitate live capture of data under dynamic conditions. To the best of 
our knowledge, the SmartPill® has not been used in pigs under condi-
tions simulating preclinical porcine food effect studies. 
The main objective of this work was to explore GI conditions in pigs 
by determining pH values, pressure and temperature by the use of a 
telemetric motility capsule (SmartPill®). Though this, the impact of food 
intake on the GI conditions was also investigated and compared with 
fasted state conditions. The secondary goal of this work was to compare 
the pig model to the more commonly used dog model, which will 
facilitate a more critical informed decision on which preclinical species 
to select in drug product development and investigation of formulation 
behaviour. Furthermore, the data from this study were compared to 
recent SmartPill® studies conducted in humans. 
2. Materials and Methods 
2.1. Materials 
All food components used in preparing FDA recommended breakfast 
were purchased commercially and are listed in Table 1. 
2.2. Telemetric motility capsule (TMC) system 
The SmartPill® GI Monitoring system was used to measure GI con-
ditions: (I) pH, (II) temperature, (III) pressure. Therefore, a data receiver 
was fixed close to each animal to record the data transferred from the 
capsule. 
2.2.1. Calibration 
Before the administration, the correct functioning of the capsules 
was verified in terms of pH, pressure and temperature. The intactness of 
the pressure sensor was tested over a range of 0 – 400 mbar with the aid 
of a manometer. A calibration with five different pH values ranging from 
pH 1.0 – 10.0 was used, using a calibrated pH meter (model 3510, 
JENWAY). After excretion, the same calibration procedure was used to 
account for the known drift of the pH sensor. The temperature sensor 
was checked with a one-point calibration at room temperature. 
2.2.2. Data analysis 
Temperature compensation for pH value and pressure was performed 
automatically by the corresponding MotiliGI® software. Also the base-
line pressure was automatically corrected by the software. However, it 
was chosen to refrain from using these baseline corrected pressure data 
as these were only relative data, which did not represent the real values 
measured in vivo. Thus, only temperature compensated pressure and pH 
data as well as the original temperature data were used for data analysis. 
All datasets were analysed with the aid of Origin 8.5.1G (OriginLab 
Corp., Northampton, USA). 
Gastric emptying time (GET), colonic arrival time (CAT) and small 
intestinal transit time (SITT), were determined by considering signifi-
cant pH changes. Gastric emptying was identified by a significant per-
manent pH change to pH 5 or higher and maximum pressure events 
above 300 mbar (225 mmHg) as these are typically limited to the 
stomach (Koziolek et al., 2019). Colonic entry was identified by a sharp 
pH decrease of at least 0.5 pH units. Capsule secretion was identified by 
a drop in temperature. 
As a consequence of the observed pH drift of the capsule sensor, the 
pH values were corrected based on the results of the post-calibration. 
Table 1 
Composition of high-fat, high-caloric meal fed to pigs in the current study  
Component Approximate weight 
(g) 
Approximate total calories 
(kcal) 
One slice of bacon 30 70 
1 slice buttered toast 45 100 
1 fried egg 60 92 
4oz (118mL) whole milk 122.5 70 
2oz hashed brown 
potatoes 
57.5 112 
Total 315 g 444 kcal  
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Following the equation 1 







where pHm is the measure pH value by the capsule, Δ pH is the mean pH 
drift calculated from the values determined during calibration, which 
was performed before administration and after excretion, WGTT is the 
whole gut transit time in hours and t is the time in hours after the 
administration of the capsule. The small intestinal transit time (SITT) 





where SITTnorm is the normalized small intestinal transit time in hours, t 
is the time in hours after capsule intake, GET is the gastric emptying time 
in hours, and CAT is the colon arrival time in hours. The data was 
characterised by minimum, maximum, range, median, arithmetic mean 
including the standard deviation where appropriate. 
2.3. Animals 
Male landrace pigs (15 – 17 kg) were sourced locally and housed 
individually at the University’s Biological Services Unit. Throughout the 
study pigs were fed approximately 175 g of standard weanling pig pellet 
feed twice daily. Initially four pigs were enrolled in this study in a 
crossover design. However, an additionally four pigs were subsequently 
included, as in three pigs the SmartPill® was not emptied from the 
stomach until the battery was completely empty (P3, P6, P44) and one 
pig vomited after the administration of the telemetric capsule (P4) and 
has been excluded. For the remaining four pigs (P1, P2, P5, P48) a two- 
way crossover of fasted and fed administration of the SmartPill® was 
obtained. 
2.4. Study protocol 
The study was carried out under the licence issued by the Health 
Products Regulatory Authority (HPRA), Ireland, as directed by the 
Cruelty to Animals Act, Ireland and EU Statutory Instruments (Licence 
number AE19130/P058). Local University ethical committee approval 
was obtained. 
A two-way, cross-over study was conducted in four landrace pigs, a 
two-week period was used between each group. The SmartPill® was 
administered together with 50 mL of water. In the fasted arm of the 
study, the final feed of 175 g of pellet food was given 24 h prior to 
dosing. The design of the study was to remove any uneaten food 16 
hours before the administration of the SmartPill. At this time, however, 
no food residue remained in any of the groups. In the fed state, pigs were 
fed half a portion of a standard high-caloric, high-fat FDA breakfast (444 
kcal, 315 g). The mass of the FDA breakfast fed equated to approxi-
mately 18 – 20 g/kg of body weight. For fed state conditions, the pigs 
received the meal 30 min prior to oral dosing of the SmartPill®. After 
dosing, pigs were returned to their pens. All pigs were fed 175 g of pig 
feed 8 h post dosing (pig weanling food which was considered a normal 
or ‘standard’ feed for landrace pigs of this size – equivalent to 20 % 
protein, 6.5 % oil, 3.5 % fibre or 987 kcal in total). Water was restrained 
for 3 h post dosing. In Fig. 1, the study of fasted and fed conditions is 
visually summarized. 
3. Results 
Overall whole gut transit time (WGTT) was successfully determined 
using SmartPill® capsules in four landrace pigs (P1, P2, P5, P48) in a 
two-way crossover of fasted and fed state. The fasted and fed study 
conditions were based on previous established study protocols, utilizing 
a standard high-caloric, high-fat FDA breakfast (Henze et al., 2019). 
Individual profiles of SmartPill® data obtained are illustrated in Fig. 2. 
As explained in the methods, in three pigs (P3, P6 & P44) the SmartPill® 
capsule remained in the stomach for more than a week until the battery 
was completely discharged. They were therefore excluded from the 
study. 
3.1. Transit times 
The transit times of the SmartPill® under fasted and fed state con-
ditions are summarized in Table 2. Gastric emptying time (GET) under 
fasted conditions ranged from 68 –233 h in the four pigs (P1, P2, P5, 
Fig. 1. Study protocol, illustrated a summary of conditions for fasted and fed treatments.  
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P48) that completed the study. In addition, two fasted pigs (P3 and P44) 
displayed a GET of >168 h (P3) and >240 h (P44), as the SmartPill® 
remained in the stomach. In the fed state GET ranged from 20 –118 h in 
four pigs, while for one additional pig GET was >264 h (P6) as the 
SmartPill® remained in the stomach. Consistently in each individual pig 
a lower GET in the fed state compared to GET in the fasted state was 
observed. On average GETfed was 3.1-fold lower compared to GETfasted. 
Small intestinal transit time was not affected by the prandial state, 
ranging from 2.3 - 4.0 h. The observed colonic transit time in the fasted 
state was relatively short in comparison to the fed state. Overall, no 
differences in the whole gut transit time was found between the dosing 
in the fasted and fed state conditions. 
Fig. 2. Individual profiles of SmartPill® data obtained in four landrace pigs (P1, 2, 5, 48) after fasted and (left) fed administration (right).  
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3.2. pH values 
The pH profiles are illustrated in Fig. 3 for fasted and fed state 
conditions. In the fasted state, for two pigs a general consistent low pH 
was observed throughout the sampling time, whereas in P5 the pH was 
higher (~ pH 4) for up to 1 h post administration and in the case of P1, 
the gastric pH was around pH 6 in the first 2 h post administration. 
Variability was confined to the first 1 - 2 h for both conditions. The short 
intervals of pH spikes under fasted condition beyond 3 h may have 
correlated with drinking water access, as pigs were allowed free access 
to water 3 h post dosing. In the fed state, elevated pH up to pH 8 were 
observed initially, which returned to basal acidic levels 2 h post dose. 
After the initial 2 h the pH was consistently lower. The minimum pH 
values ranged from pH 0.2 – 0.6 under fasted conditions and fed 
conditions. 
An overview of the individual pH profiles in the porcine small in-
testine can be seen in Fig. 4. Given that the time to enter the small in-
testine regions was >20 h, and pigs were fed 8 h post dosing regular pig 
food in both study arms, from here on we cannot truly define fasted and 
fed profiles. In the intestinal regions, the pH values ranged from pH 6.2 – 
7.5 during the first hour. At the end of the small intestinal transit the pH 
values were slightly in the range of pH 7.6 - 8.0. The pH values detected 
in the colon of landrace pigs were equal under fasted and fed conditions 
(Fig. 5), with a range of pH 5.2 – 7.8. 
3.3. Pressures 
The maximum pressures detected in the stomach in landrace pigs are 
illustrated in Fig. 6. The maximum pressure in the stomach compart-
ment were higher compared to the observed data in the small intestine. 
Furthermore, the maximum pressures in the fed stomach were more 
variable and slightly lower compared to the fasted state. The maximum 
pressures in the small intestine were in the same range (< 100 mbar) for 
fasted and fed conditions (data not shown). 
4. Discussion 
4.1. Transit times 
In this study, the GI transit times of the SmartPill® were successfully 
determined in a cross-over design in four male landrace pigs in fasted 
and fed state. Overall, WGTT obtained with the SmartPill® was similar 
between fasted and fed state conditions of the four pigs. The transit times 
through the porcine small intestine were much more consistent than for 
the gastric compartment. SITT range between 2.3 - 4.0 h, these values 
Table 2 
Individual transit times of the SmartPill® administered in four male landrace pigs under fasted and fed conditions. GET – gastric emptying time; CAT – colonic arrival 
time; SITT – small intestinal transit time; CTT- Colon transit time; WGTT – whole gut transit time.  
Pig GET SITT CAT CTT WGTT 
fasted fed fasted fed fasted fed fasted fed fasted fed 
1 92 h 22 h 2.6 h 2.3 h 95 h 25 h 83 h 169 h 177 h 194 h 
2 68 h 43.4 h 3.2 h 2.6 h 71 h 46 h 32 h 83 h 103 h 129 h 
5 233 h 118 h 3.2 h n.a. * 235 h n.a. * 21 h > 140 h * 257 h 262 h 
48 94 h 20 h 4.0 h 3.8 h 98 h 24 h 79 h 55 h 177 h 79 h  
* Signal loss 
Fig. 3. Comparison of individual gastric pH over the first 5 h after administration of the SmartPill® in male landrace pigs- fasted state (A), fed state (B), n= 4  
Fig. 4. Comparison of individual small intestinal pH ranges after administra-
tion of the SmartPill® in male landrace pigs under fasted and fed conditions 
(pig 5 no fed state data due to signal loss); Pigs, for whom post-calibration was 
not possible are not included in the figure (pig 2 fasted, pig 5 fasted). 
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were in good agreement with reported SITT in humans (3 - 5 h) 
(Koziolek et al., 2015). The mean colonic transit time in this study was 
highly variable (Table 2) and overall no significant differences could be 
observed between fasted and fed pigs. The high variability was in line 
with previously reported colonic transit times measured by roentgen-
ography in fasted pigs, which ranged between 48 – 792 h (Davis et al., 
2001). 
For additional three pigs, the capsule remained in the stomach until 
the battery was completely empty, individual SmartPill® profiles are 
provided in Fig. S1 (supplementary data). The study confirms that GET 
for non-disintegrating dosage forms is extremely variable in pigs. While 
Hossain and co-workers used a different technique, the same effect for 
non-disintegrating dosage forms was observed. Hossain et al. investi-
gated the gastric emptying of a variety of different non-disintegrating 
dosage forms in pigs by roentgenography and reported gastric transit 
time of more than 120 h in some cases (Hossain et al., 1990). For 
instance, large-size plastic tablets (20 mm x 8 mm) had gastric emptying 
times of 24 – 672 h. However, this study was limited and only included 
two pigs that were repeatedly dosed for a prolonged period. 
In our study, post mortem investigations revealed that the capsule was 
still in the stomach of the three pigs after more than 168 h, 240 h and 
264 h, respectively. This phenomenon had already been described in the 
literature for Göttingen minipigs (Suenderhauf and Parrott, 2013) and 
Yucatan minipigs (Oberle and Das, 1994), were the telemetric device 
was recovered from the stomach. During necropsy, the SmartPill® was 
recovered from the area of the Torus pyloricus. This area is a protuber-
ance consisting of fat and muscle fibres, which lies in the muscle-free gap 
of the sphincter. The pylorus in pigs is relatively stenotic, and thus 
difficult to overcome for large dosage forms (Suenderhauf and Parrott, 
2013). Furthermore, the porcine stomach is “U-shaped”, in contrast to 
the “J-shaped” stomach of humans, which can additionally hamper the 
emptying of large non disintegrated dosage forms. During stomach 
contractions, the dosage form would have to be forced upwards toward 
the pylorus in pigs and the contractions tended to narrow this region, 
which may further result in prolonged retention (supporting material, 
video). This phenomenon also explains why in both prandial states very 
long gastric transit times have been observed, which were clearly longer 
than gastric transit times of SmartPill® reported in recent studies in dogs 
and humans (Koziolek et al., 2019; Koziolek et al., 2015). Such long 
gastric transit times have also previously been reported in pig studies 
(Davis et al., 2001; Oberle and Das, 1994). 
The reasons for the particularly long and variable gastric transit 
times in this study remained unclear, but may be related to the char-
acteristics of the Migrating Motor Complex (MMC) in pigs. This motility 
pattern is present only in the fasted state and is interrupted and replaced 
by fed state motility pattern upon feeding. The MMC can be described by 
a sequence of three phases of different lengths and intensity. In humans, 
the emptying of large, non-disintegrating dosage forms occurs primarily 
during phase III of the MMC. Due to species-specific features of GI tract, 
differences in cycle and phase duration exist. In pigs, the MMC arrival is 
related to the feeding frequency and shows a slightly faster motor ac-
tivity. MMC cycle has a length of 75-80 min in pigs and about 90 – 150 
min in humans (Romanski, 2009). Oberle et al. suggested that although 
the fasted MMC in pigs resembles that in humans, the mechanism of 
gastric emptying of large objects appears to be unrelated to phasic ac-
tivities in pigs (Oberle and Das, 1994). Table 3 provides an overview of 
studies reported in the literature using non-disintegrated dosage forms 
to detect GI transit. Overall, long GET has been reported across four 
different species of pigs, and GET does not appear to be related to the 
size of the device relative to the size of the pigs. For example, Suen-
derhauf et al. used the Bravo pH system (6 × 5.5 × 25 mm) in Göttingen 
minipigs (~ 15 kg), and observed that the capsules stayed at least 48 h in 
the stomach (Suenderhauf and Parrott, 2013). Whereas, Oberle and 
co-workers used the Heidelberg capsule (7 mm diameter, 20 mm long) in 
Yucatan minipig (19 - 40 kg), the capsule was not emptied form the 
stomach for at least 54 h in one specific case (Oberle and Das, 1994). 
Hossain et al. suggested that the motor activity in pigs might be less 
efficient in emptying large indigestible dosage forms from the stomach 
in comparison to humans or dogs (Hossain et al., 1990). However, the 
maximum pressures that have been observed in this study were in the 
Fig. 5. Comparison of individual colonic pH ranges after administration of the 
SmartPill® in male landrace pigs. Pigs, for whom post-calibration was not 
possible are not included in the figure (pig 2 fasted, pig 5 fasted). 
Fig. 6. Maximum pressures in stomach under fasted and fed conditions 
measured in landrace pigs (n = 4, line indicates the mean) 
Table 3 
Overview of gastrointestinal studies conducted in pigs in comparison to this 
study in Landrace pigs.  
Different gastrointestinal studies conducted in pigs Ref. 
Breed Body 
Weight 






Landrace pigs 15 -17 
kg 
26 × 13 mm 68 – 233 h 4  
Yorkshire pigs 45 kg 20 mm x 8 
mm 
24 – 672 h 2 1 
Yucatan 
minipigs 
19 – 40 
kg 
7mm x 20 
mm 
> 54 h 3 2 
Göttingen 
minipigs 
~ 15 kg 6 × 5.5 × 25 
mm 
> 48 h * 3  
1 :(Hossain et al., 1990); 
2 :(Oberle and Das, 1994); 
3 : (Suenderhauf and Parrott, 2013); 
* Not reported 
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same range as reported for humans (Koziolek et al., 2015; Schneider 
et al., 2016). Therefore, another hypothesis could be that the smaller 
diameter of the pylorus of the pigs may prevent or hamper the gastric 
emptying of ingestible objects, in the present study the dosed SmartPills. 
Gastric emptying of the SmartPill® was mainly observed in the 
morning, usually around 6 – 8 am. Hence, the time between the last 
feeding step in the late afternoon and gastric emptying was 13.6 ± 1.1 h. 
Table 4 presents a summary of last feeding and gastric emptying of the 
non-disintegrated capsule. By comparison, a recent published study in 
humans reported that gastric emptying of SmartPill® after fed admin-
istration also occurred mainly at night, with a last meal intake 7.8 ± 2.3 
h before gastric emptying of the SmartPill®. 
With respect to the effect of food intake on gastric emptying, it can be 
stated that food did not significantly delay the GET of the SmartPill® in 
this study when compared to the fasted state. This observation was in 
contrast to recent data in human and beagle dogs (Koziolek et al., 2019). 
The mean gastric emptying in the fed state was around 50 h in landrace 
pigs, however, the data between the pigs was highly variable ranging 
from 20 - 118 h. Nevertheless, consistently in each individual pig a lower 
GET in the fed versus the fasted state was observed (Table 2). On average 
GETfed was 3.1-fold lower compared to GETfasted in each pig. In certain 
pigs, due to anatomical or physiological aspects, an exceptional long 
GET was evident under both conditions, this seems to be pig specific. For 
example, for P5 a very long GET was evident under fasted (230 h) and 
fed (118 h) state conditions (Table 2), whether this reflected the size of 
the tours pyloricus or other aspects influenced gastric transit was not 
clear. Overall, it seemed that gastric emptying time in the fed state was 
not affected in the same way by the anatomical properties of the pig 
stomach as under fasted conditions. 
4.2. pH values 
The fasted gastric pH profiles initially ranged from pH 2.0 to pH 7.0, 
but dropped to highly acidic pH values of approximately pH 1.8 after the 
first 2 h. The obtained gastric profiles in fasted landrace pigs showed a 
high intra-individual variability. Fluctuations in gastric pH profiles can 
occur due to the dynamic deposition behaviour of the capsule (i.e., when 
the capsule come in contact with mucosa and then moves away again). 
This effect may lead to the observed high variability of the measured 
initial pH. The data in this study corresponded well with existing liter-
ature investigating the GI conditions in pigs (Hossain et al., 1990; 
Oberle and Das, 1994; Suenderhauf and Parrott, 2013). In addition, 
these values were closely in line with recently published pH values from 
GI fluid samples, collected post mortem in landrace pigs, where a similar 
range of pH 1.7 – 3.4 was found under fasted conditions. It should also 
be noted, when using a telemetric capsule a discrepancy in pH values 
may exist initially when compared to samples collected post-mortem, as 
the capsule was administrated together with 50 mL of water, which may 
influence the gastric pH values (Koziolek et al., 2019). Nevertheless, 
these findings confirm that the SmartPill® GI monitoring system is 
suitable to obtain realistic pH data in a minimally intrusive fashion 
(Fuchs and Dressman, 2014). In the present work, the pH decreased in 
the fed state within 2 h to strongly acidic baseline levels (Fig. 3). The 
feeding 30 min prior to TMC intake stimulated gastric acid secretion, 
which may cause a fast drop of pH due to the strongly acidic character of 
the gastric section. 
The pH difference between the stomach and the proximal small in-
testine may play a role in a pH-dependent absorption, but moreover it is 
very important for the evaluation of precipitation of poorly water- 
soluble drugs with a weakly basic character. The fasted small intesti-
nal pH determined in this study ranged from pH 6.7 – 7.5 in the duo-
denum and pH 7.6 – 8.0 in the ileum. These values were comparable to 
intestinal landrace pig data sampled under post mortem conditions (pH 
6.3 – 7.9). While on one hand, pH can be measured directly in the GI 
tract using telemetric systems, post mortem examination of intestinal 
fluids are an alternative approach. However, sampling under post mor-
tem conditions may influence the measured pH, whereas the usage of a 
telemetric capsule can detect a more dynamic pH profile along the GI 
tract, while this may better resemble the pH an administered dosage 
form is exposed upon intake. 
In most of the pigs, a strong duodenogastric reflux was observed. 
Short durations with higher pH values could be observed 3 h prior to 
gastric emptying. An example is illustrated in Fig. 7. Based on the 
observed data a correlation of pH increase and a distinct high pressure 
was seen in the fasted state (Fig. 7 A), indicating that the reflux may be 
associated with intensive motility pattern (MMC phase III). However, in 
the fed state the strong pressure events were not related to the pH in-
crease, the MMC was probably interrupted and replaced by continuous, 
medium intensity kind of, contractions upon feeding. The observation 
that a strong reflux occurred in pigs, was further support by a recently 
published study in landrace pigs, where high levels of bile acid con-
centration could be observed in the gastric compartment (2.5 mM) 
which was 8-fold higher compared to reported gastric bile levels of 
humans (Henze et al., 2020a). Nonetheless, reflux from the intestine into 
the stomach, is also a common physiological phenomenon in humans 
(Castedal et al., 2000; Koziolek et al., 2015). 
4.3. Pressures 
Insights into pressure patterns as well as the intensity of pressures in 
the GI tract are of great interest, as for some formulations, drug release 
can be affected by physiological pressure events. In particular, the drug 
release from hydrogel matrix tablets, one of the most common ap-
proaches for extended release formulations, can be influenced by the 
pressures occurring in the stomach. The maximum pressures observed in 
landrace pigs were up to 402 mbar in the stomach with an average of 
349 ± 84 mbar under fasted conditions, and 250 ± 103 mbar in the fed 
state. The data obtained in fasted pigs were generally higher than the 
data from the fed animals, which may be related to the intense peristaltic 
waves (MMC Phase III) in the stomach. On transfer into the small in-
testine the intestinal pressures were significantly lower, with the highest 
pressure measured in the intestine of 99 mbar. 
4.4. Comparison of porcine GI transit data with data from dogs and 
humans 
A final objective of this study was to perform a comparison of the GI 
transit times between landrace pigs, beagle dogs and humans, as pre-
sented in Table 5. With respect to gastric transit times in humans, the 
GET obtained in landrace pigs was longer, it may correlate to the 
distinctive anatomical characteristics of the porcine stomach as was 
already outlined above, whereas GET obtained in beagle dogs has been 
reported to be much shorter (Koziolek et al., 2019). One possible 
explanation of the variation between the species might be the study 
protocol and more specifically, the meal composition. Table S1 (sup-
plementary data) summarizes the study conditions from landrace pigs, 
beagle dogs and humans. While in all of the three studies a similar type 
of food, containing eggs, toast, milk etc. had been used, the amount of 
kcal per bodyweight varied. In the reported human study, a high-caloric, 
high-fat standard meal (FDA breakfast) was used for postprandial 
Table 4 
Relation of the time when gastric emptying (GE) of the SmartPill® occurred, to 
the last meal intake before GE.  
Pig Fasted Fed FDA breakfast  
GE daytime 
[hh:mm] 
Last meal intake 
before GE [h] 
GE daytime 
[hh:mm] 
Last meal intake 
before GE [h] 
1 05:39 12.49 08:25 14.27 
2 06:03 12.70 06:17 12.28 
5 03:17 14.78 06:25 13.56 
48 07:40 13.42 06:22 12.78  
L.J. Henze et al.                                                                                                                                                                                                                                 
European Journal of Pharmaceutical Sciences 156 (2021) 105627
8
conditions. This test meal is recommended by FDA and EMA for human 
food effect studies and contains 965 kcal, which translate into a 13.8 
kcal/kg bodyweight ratio (Koziolek et al., 2015). In this study with 
landrace pigs, a test meal of 444 kcal (half portion of the FDA breakfast) 
was used, which was based on a recent finding that for food effect 
studies conducted in landrace pigs a higher caloric FDA breakfast is 
necessary (Henze et al., 2019). This translates into a 26.1 kcal/kg 
bodyweight ratio. In a recent study with beagle dogs, the fed state was 
simulated by administration of a modified FDA meal of ~ 11.3 kcal/kg 
bodyweight (Koziolek et al., 2019). The meal intake after dosing is also 
different for the reported studies. While in studies conducted in humans, 
lunch was provided 4.5 h after ingestion of the SmartPill®, beagle dogs 
got standard dog food 4 h after SmartPill® administration. In this study, 
landrace pigs got pig standard weaning food 8 h after SmartPill® 
administration. All in all, it can be summarized that the high-caloric 
density of the food and deviations in the study protocols, in terms of 
meal intake prior and post dosing, may have influenced gastric transit 
conditions. However, there are also differences between the species that 
are not completely defined by the food protocol, that may have led to 
GET differences across the species. 
The transit times through the porcine small intestine were similar to 
human conditions, whereas in contrast dogs display a shorter SITT of 1 – 
2 h (Table 5). It has been suggested that the shorter intestinal transit 
times can be correlated to different dimensions of the small intestine. In 
dogs, the small intestine appears to be shorter compared to humans and 
pigs (Koziolek et al., 2019). The small intestinal physiology is generally 
comparable between pigs and humans, which is considered favourably 
in the context of similarity of the drug absorption process for both 
(Henze et al., 2018b). Overall, this study further supports these findings, 
in that the transit in the primary absorptive region of the GI tract was 
broadly similar, further supporting the suitability of the pig model to 
evaluate the kinetics of drug absorption of immediate release dosage 
forms. 
In pigs, mean colonic transit times are in general longer in compar-
ison to humans, but also very variable (Koziolek et al., 2015; Schneider 
et al., 2016). In dogs the average colonic transit time was reported to be 
slightly higher in comparison to human colonic transit times (Koziolek 
et al., 2019). Colonic transit times are important when evaluating 
extended release (ER) formulations, and it is critical that allowances are 
made for the generally longer colonic residence times of 
non-disintegrating dosage forms observed in pigs and dogs, when 
extrapolating to humans. Overall these findings would suggest that for 
sustained release monolithic dosage forms that the potential window for 
drug release is likely to be exaggerated in dogs, and even more so in pigs. 
By comparing the present data set in landrace pigs to recently pub-
lished studies in humans, it can be seen that gastric pH observed under 
fasted and fed conditions was in the range of humans (Fig. 8). In 
contrast, it has been shown that dogs have an elevated gastric pH, which 
could lead to issues when evaluating enteric coated formulation and 
their potential in vivo performance, which can be overcome by penta-
gastrin administration (Koziolek et al., 2019). 
In comparison to human fasted intestinal conditions, duodenum pH 
5.3 – 6.4 (median pH 5.9), ileum pH 6.8 – 7.6 (median 7.5) (Schneider 
et al., 2016), the data observed in landrace pigs was marginally higher, 
although the typically pH increase from the proximal to the distal parts 
of the intestine can be seen for both humans and pigs (Fig. 9). In com-
parison to the observed data in pigs, dogs have a similar pH, recently 
published, canine intestinal pH data, revealed that dogs also show a 
higher pH when compared to humans (Koziolek et al., 2019). 
The colonic pH values in pigs and humans were in the same range 
(range: 5.2– 7.8), as illustrated in Fig. 10. A similar pH range has been 
reported for dogs (pH 5.0 – 8.0). Nonetheless, colonic pH values are 
variable, Koziolek and co-workers hypothesized that observed changes 
in pH values indicate transit through the colon, whereas constant pH 
values might be a sign that the telemetric capsule stayed at a certain 
region within faecal contents. In dogs, relatively long durations of 
constant pH have been measured in the colon, a similar effect can be 
observed in pigs in the present study. 
In humans, high pressure activity has been reported in the stomach 
with maximum pressures up to 500 mbar (Koziolek et al., 2015; 
Schneider et al., 2016). In comparison to reported human data, the data 
obtained in this study showed that the pigs displayed similar maximal 
pressure values (402 mbar), and were closer in mimicking human 
Fig. 7. Gastric profile 3 h prior to gastric emptying, example of P2, on the left-hand side (fasted) and right-hand side (fed).  
Table 5 
Transit times of the SmartPill® administered in four male landrace pigs under 
fasted and fed conditions (mean ± SD, n=4), compared to published literature of 
humans and beagle dogs; GET – gastric emptying time; CAT – colonic arrival 
time; SITT – small intestinal transit time; CTT- Colon transit time; WGTT – whole 
gut transit time.   
Landrace pigs Humans Beagle dog c  
Fasted Fed FDA 
breakfast
1 
Fasted Fed FDA 
breakfast
2 



























































1 444 kcal 
2 965 kcal = 13.8 kcal/ kg bodyweight 
3 150-200 = 11.3 kcal/kg bodyweight = homogenized meal 
a (Schneider et al., 2016) 
b (Koziolek et al., 2015) 
c (Koziolek et al., 2019) 
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stomach conditions than dogs. In beagle dogs, gastric maximum pres-
sures of 800 mbar have been reported, which was significantly higher 
than the reported human values (Koziolek et al., 2019). Koziolek and 
co-workers emphasized that dogs could still be a useful species to 
evaluate modified release formulations as a worst-case scenario in terms 
of mechanical stress occurring in the GI tract. Higher pressures in the 
stomach may result in unexpected drug release scenarios; such as dose 
dumping. This is suggested to make the dog model attractive and useful 
to assess the uncertainty of dose dumping of extended release formu-
lations under conditions of elevated gastric pressure. Nevertheless, the 
pig model may offer the advantage for general pharmacokinetic studies 
to represent more human like conditions in terms of pressure activity in 
the stomach. The pressures during small intestinal passage were 60 ± 35 
mbar in humans, which was comparable to the observed pig data. The 
intestinal maximum pressure measured in beagle dogs is approximately 
200 mbar, reflecting a 3.3-fold increase compared to humans and pigs. 
4.5. The pig as a preclinical model within drug formulation development 
While it is commonly recognised that there is no ‘ideal’ species that 
represent all aspects of human GI conditions, favourable correlations 
between pig and human bioavailability values have generally been 
supportive of the suitability of the pig model for gaining first insights 
into in vivo absorption parameters of new drug products (Henze et al., 
2018b). However it has been noted that the rate of drug absorption was 
generally slower in pigs than in humans, resulting in a rule of thumb that 
reported tmax in pigs were on average 2-fold higher than observed tmax 
Fig. 8. Comparison of initial individual gastric pH values observed in landrace pigs (n=5,6) and humans (n=9) (Schneider et al., 2016) after fasted and fed state 
administration of the SmartPill® (line is indicating median). 
Fig. 9. Comparison of small intestinal pH values observed in landrace pigs 
(blue n= 4) and humans (grey, n= 19) after administration of the SmartPill®. 
Human data were published recently by Koziolek and co-workers (Koziolek 
et al., 2019). 
Fig. 10. Comparison of colonic pH values observed in landrace pigs (A, n= 4) and humans (B, n= 19) after administration of the SmartPill®. Human data were 
published recently by Koziolek and co-workers (Koziolek et al., 2019). 
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data in humans for the same drug (Henze et al., 2018b). The current 
study provided additional insights to explain the slower rate of ab-
sorption observed for a variety of drugs, reflecting a slower overall 
clearance from the stomach. Once presented to the intestine, given the 
similar small intestinal transit time, drug absorption kinetics are likely 
to be well matched between pigs and humans. In general, this study 
therefore supports the suitability of the pig model for assessing the ab-
sorption kinetics of immediate release oral dosage forms in humans. 
However, in the case of large non-disintegrating tablets/capsules, the 
study confirms that such dosage forms are likely to likely to display a 
variable and extended gastric residence time in pigs, and hence caution 
is advised when extrapolating absorption kinetics for such monolithic 
drug products from pigs to humans.. 
In terms of modified release formulation, the choice of animal model 
requires careful consideration. For enteric coated formulations, the 
lower pH in pigs would tend to be a better guide to performance in 
humans, however, this needs to be balanced with the highly variable 
GET for non-disintegrating dosage forms. In the case of enteric coated 
pellets (e.g. 0.9-1.5 mm in diameter) the pig model may still be suitable, 
as the smaller sized pellets are less likely to be impeded at the Torus 
pyloricus (Davis et al., 2001). In general, for sustained release formula-
tions, where the drug may be intended to be released over an extended 
period of time, the GET may be a critical parameter in predicting the 
performance of the formulation in humans. For gastro-retentive dosage 
forms, the findings in this study also potentially shed new insights on the 
utility of the pig. While pigs have been used to investigate 
gastro-retentive devices (Brayden and Baird, 2019; Kirtane et al., 2018), 
based on the observations with SmartPill® data presented here, it is 
questionable whether observation in pigs, which most likely reflect the 
delayed clearance of larger devices from the stomach, will reliably 
translate to humans. However, in a situation where worst-case evalua-
tion of a modified release dosage form, such as to assesses the risk of 
dose dumping during prolonged gastric residence, the pig model may 
therefore be considered a suitable approach. 
5. Conclusion 
The study showed that the data observed in pigs, using the Smart-
Pill® was closely aligned to reported SmartPill® data in humans. 
However, the study demonstrated that gastric transit times of non- 
disintegrated dosage forms was variable and prolonged in pigs, 
compared to studies conducted in humans. Therefore, while this study 
supports the suitability of the pig model for evaluation immediate 
release oral dosage forms, the findings confirm a limitation of the 
porcine model when used for the evaluation of gastro-retentive and/or 
large non-disintegrating oral dosage forms, which are likely to display 
an extended gastric residence time, in pigs. Nonetheless, it was shown 
that the small intestinal transit conditions in pigs were similar to 
humans, and detected GI pH values and pressures, were comparable 
between pigs and humans. The fed state GET in pigs, unusually appeared 
to be shorten in all pigs comparted to fasted conditions, which was in 
contrast to reported effects in humans. By comparing the observed 
SmartPill® data in landrace pigs, with recent data from beagle dogs, it 
was demonstrated that important differences exist between these pre-
clinical species, that should carefully be taken into account when 
selecting an appropriate model for specific formulation strategies. 
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